Veterinary Medicines

MILOXAN ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Not authorised
  • Clostridium chauvoei, toxoid
  • Clostridium sordellii, toxoid
  • Clostridium tetani, toxoid
  • Clostridium novyi, toxoid
  • Clostridium septicum, toxoid
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
Download as PDF

Product identification

Medicine name:
MILOXAN ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Clostridium chauvoei, toxoid
  • Clostridium sordellii, toxoid
  • Clostridium tetani, toxoid
  • Clostridium novyi, toxoid
  • Clostridium septicum, toxoid
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
Target species:
  • Goat
  • Sheep
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium chauvoei, toxoid
    1.00
    100% protective dose
    /
    2.00
    millilitre(s)
  • Clostridium sordellii, toxoid
    1.00
    100% protective dose
    /
    2.00
    millilitre(s)
  • Clostridium tetani, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)/dose
  • Clostridium novyi, toxoid
    3.50
    international unit(s)
    /
    1.00
    millilitre(s)/dose
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    1.00
    millilitre(s)/dose
  • Clostridium perfringens, type B and C, beta toxoid
    10.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    5.00
    international unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Goat
      • Not applicable
        no withdrawal period
    • Sheep
      • Not applicable
        no withdrawal period
    • Cattle
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR05DA12
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 6739-05-03-1992/31-03-1992/K-0044101
Date of authorisation status change: